Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Arisa Okamasa"'
Autor:
Paul Gillard, Tsuyoshi Tamura, Haruo Kuroki, Yoshiyuki Morikawa, Leentje Moerman, Jose Parra, Yurina Kitamura, Kazuko Mihara, Arisa Okamasa
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 4, Pp 800-808 (2019)
Rotavirus infections have been reported to account for 40–50% of all hospitalized acute gastroenteritis cases in young children (
Externí odkaz:
https://doaj.org/article/b2b365a72533464cace6baf258896df3
Autor:
Terufumi Shimoda, Hiroshi Odajima, Arisa Okamasa, Minako Kawase, Masaki Komatsubara, Bhabita Mayer, Steven Yancey, Hector Ortega
Publikováno v:
Allergology International, Vol 66, Iss 3, Pp 445-451 (2017)
Background: The MENSA trial assessed the efficacy and safety of mepolizumab in patients with severe eosinophilic asthma. This report describes the efficacy and safety of mepolizumab in Japanese patients from MENSA. Methods: A post hoc analysis of the
Externí odkaz:
https://doaj.org/article/af810f598c7e47d2ae3d79659ee6958d
Publikováno v:
Allergology International, Vol 64, Iss 1, Pp 60-65 (2015)
Background: Fluticasone furoate nasal spray (FFNS) is a glucocorticoid developed for the treatment of allergic rhinitis (AR). This study aimed to assess the safety, efficacy, and systemic exposure of FFNS in Japanese children with perennial AR (PAR).
Externí odkaz:
https://doaj.org/article/33c322d05004416196be66356fa5ef9e
Publikováno v:
Allergology International, Vol 63, Iss 4, Pp 543-551 (2014)
Background:: Fluticasone furoate nasal spray (FFNS) is a glucocorticoid developed for the treatment of allergic rhinitis (AR). This is the first randomized clinical trial to assess the efficacy and safety of FFNS in Japanese children with perennial A
Externí odkaz:
https://doaj.org/article/09c18439311849c1a589539263cc8b62
Autor:
Arisa OKAMASA, Malek OKOUR, Daren AUSTIN, Yuri SHIDA, Jennifer E. SAGER, Elizabeth ALEXANDER, Dimitra BRINTZIKI, Amina HAGGAG, Stephen A. HARRISON, Takako HATTORI, Ian HAWES, Nobuhiko OKUDA, Scott SEGAL, Andrew SKINGSLEY, Robert WILLIAMS, Esther YOON, Andrew M. LIPPA
Publikováno v:
Kansenshogaku Zasshi. 96:39-45
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::183a4ef44b5728e181056776f559cd06
https://doi.org/10.11150/kansenshogakuzasshi.96.39
https://doi.org/10.11150/kansenshogakuzasshi.96.39
Autor:
Arisa Okamasa, Leentje Moerman, Tsuyoshi Tamura, Paul Gillard, Yoshiyuki Morikawa, Haruo Kuroki, Yurina Kitamura, Jose Parra, Kazuko Mihara
Publikováno v:
Human Vaccines & Immunotherapeutics
Rotavirus infections have been reported to account for 40–50% of all hospitalized acute gastroenteritis cases in young children (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8bc2365876b4fd4f68c52aa8b96aa1f
https://doi.org/10.1080/21645515.2018.1564441
https://doi.org/10.1080/21645515.2018.1564441
Autor:
Minako Kawase, Steven W. Yancey, Hector Ortega, Hiroshi Odajima, Arisa Okamasa, Masaki Komatsubara, Terufumi Shimoda, Bhabita Mayer
Publikováno v:
BASE-Bielefeld Academic Search Engine
Allergology International, Vol 66, Iss 3, Pp 445-451 (2017)
Allergology International, Vol 66, Iss 3, Pp 445-451 (2017)
Background The MENSA trial assessed the efficacy and safety of mepolizumab in patients with severe eosinophilic asthma. This report describes the efficacy and safety of mepolizumab in Japanese patients from MENSA. Methods A post hoc analysis of the J
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6af13d4b474b0c36b2cb21888387c32f
https://doi.org/10.1016/j.alit.2016.11.006
https://doi.org/10.1016/j.alit.2016.11.006